Incyte Investor Conference Update

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq: INCY) has updated its presentation time at the following investor conference:

• JMP Securities Hematology & Oncology Forum (Virtual) on Thursday, June 18, 2020, now at 3:00 p.m. (EDT).

The presentation at the BMO Prescriptions for Success Healthcare Conference (Virtual) on Tuesday, June 23, 2020 at 1:30 p.m. (EDT) is unchanged.

The presentations for both conferences will be webcast live and can be accessed at Investor.Incyte.com. Replays will be available for 30 days.

About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200617005085/en/

Media
Catalina Loveman, +1 302 498 6171
[email protected]

Investors
Michael Booth, DPhil, +1 302 498 5914
[email protected]

Source: Incyte

You May Also Be Interested In

• Boomi and Jade Global Partner to Bring Governed AI Agents to Manufacturing Operations
• Best Enterprise Fine-Tuning Services (2026) Report Published by Metaclade Research
• KnowBe4 Research Reveals Senior Managers in Singapore are Twice as Likely to Comply With an AI-Cloned CEO Voice